Trial Profile
Vitreo retinal interface changes after Intravitreal Bevacizumab (Avastin) injection in Proliferative Diabetic Retinopathy using Spectral Domain Optical Coherence Tomography.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jun 2018
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- 22 Jun 2018 New trial record